+1,325.8%
CRWD vs MRNA
+793.7%
+532.1%
-67.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.0% | +5.4% | -6.4% | -1.4% |
| 7D | -3.0% | -1.1% | -1.9% | -2.9% |
| 30D | -6.8% | +126.1% | -132.9% | -17.5% |
| 3M | +19.6% | +190.0% | -170.4% | +1.6% |
| 6M | +87.1% | +157.2% | -70.1% | +61.0% |
| YTD | +76.4% | +388.2% | -311.8% | +36.8% |
| 1Y | +90.8% | +467.0% | -376.2% | +43.4% |
| 3Y | +380.0% | +36.1% | +343.9% | +322.5% |
| 5Y | +215.6% | -68.0% | +283.6% | +217.2% |
| All | +1,325.8% | +793.7% | +532.1% | +909.5% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling